Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
Clinical trial NCT06327815 · COMPLETED
Trial details
- NCT number
- NCT06327815
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2025-06-30
- Enrollment
- 633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.